Global X MANAGEMENT CO LLC trimmed its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 80.0% during the third quarter, HoldingsChannel reports. The institutional investor owned 2,219 shares of the healthcare conglomerate’s stock after selling 8,900 shares during the quarter. Global X MANAGEMENT CO LLC’s holdings in UnitedHealth Group were worth $435,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in UNH. Jennison Associates LLC lifted its position in UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after buying an additional 3,289,470 shares in the last quarter. Harbour Capital Advisors LLC raised its stake in shares of UnitedHealth Group by 18,383.4% during the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after purchasing an additional 2,503,090 shares during the period. Janus Henderson Group PLC raised its stake in shares of UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares during the period. Vanguard Group Inc. raised its stake in shares of UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. Finally, Parametric Portfolio Associates LLC raised its stake in shares of UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares during the period. 86.01% of the stock is currently owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group Inc (NYSE UNH) opened at $224.76 on Tuesday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market cap of $217,310.00, a price-to-earnings ratio of 25.54, a P/E/G ratio of 1.57 and a beta of 0.66. UnitedHealth Group Inc has a 12 month low of $156.09 and a 12 month high of $231.77.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.17 earnings per share. analysts expect that UnitedHealth Group Inc will post 9.99 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were paid a $0.75 dividend. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.33%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.09%.

In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. In the last 90 days, insiders sold 34,630 shares of company stock valued at $7,669,416. Insiders own 0.89% of the company’s stock.

A number of analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Cantor Fitzgerald reiterated a “buy” rating and set a $208.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, October 17th. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. Finally, Leerink Swann reiterated a “buy” rating and set a $240.00 price objective (up previously from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $226.74.

ILLEGAL ACTIVITY WARNING: “Global X MANAGEMENT CO LLC Sells 8,900 Shares of UnitedHealth Group Inc (UNH)” was reported by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.watchlistnews.com/global-x-management-co-llc-sells-8900-shares-of-unitedhealth-group-inc-unh/1799488.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.